Gouvernance Amgen Inc.

AMGN

US0311621009

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 17/06/2026			Varia. 5j.	Varia. 1 janv.
341,66 ^USD	-1,78%		+1,16%	+4,38%

15/06	AMGEN INC. : Mizuho Securities persiste à l'achat	ZM
15/06	Les géants mondiaux de la pharmacie investissent des milliards pour renforcer leur présence aux États-Unis	RE

Comité Exécutif: Amgen Inc.

Dirigeant

Fonctions occupéesDepuis

Robert Bradway

63 ans

Chief Executive Officer	01/05/2012
President	01/05/2010

Jonathan Graham

65 ans

General Counsel	13/07/2015
Corporate Secretary	13/07/2015

David Reese

63 ans

Chief Tech/Sci/R&D Officer

26/07/2018

Scott Skellenger

Chief Tech/Sci/R&D Officer

01/10/2022

Paul Burton

57 ans

Chief Tech/Sci/R&D Officer

01/06/2023

James Bradner

53 ans

Chief Tech/Sci/R&D Officer

18/12/2023

Esteban Santos

59 ans

Chief Operating Officer

25/07/2016

Derek Miller

53 ans

Human Resources Officer

01/09/2004

Matthew Busch

52 ans

Comptroller/Controller/Auditor

14/08/2023

Peter Griffith

67 ans

Director of Finance/CFO

01/01/2020

Sean Bruich

Chief Tech/Sci/R&D Officer

01/08/2024

Greg Portner

General Counsel

01/11/2005

Kave Niksefat

Sales & Marketing

01/08/2024

Sam Guhan

Chief Tech/Sci/R&D Officer

01/11/2024

Howard Y. Chang

Chief Tech/Sci/R&D Officer

16/12/2024

Mark J. Taisey

General Counsel

01/01/2014

Nancy Grygiel

58 ans

Compliance Officer

01/01/2016

Casey Capparelli

Investor Relations Contact

01/10/2025

Composition du Conseil d'Administration: Amgen Inc.

Administrateur

ComitésDepuis

Robert Bradway

63 ans

Executive Committee Chair	01/01/2013
Compensation Committee	14/10/2016
Governance Committee Chair

Robert Eckert

71 ans

Compensation Committee	26/03/2021
HR Committee	26/03/2021
Governance Committee Chair	26/03/2021
Nominating Committee Chair	26/03/2021
Executive Committee	01/01/2012
Governance Committee	20/03/2020
Nominating Committee	20/03/2020
Compensation Committee Chair

Greg Garland

68 ans

Executive Committee
Compensation Committee	16/10/2013
Governance Committee Chair
Nominating Committee Chair
Audit Committee	03/11/2025
Finance Committee	03/11/2025

Charles Holley

69 ans

Executive Committee	03/02/2017
Governance Committee
Nominating Committee	03/02/2017
Audit Committee Chair	01/04/2020
Audit Committee	04/10/2019
Finance Committee	04/10/2019

Wanda Austin

71 ans

Compensation Committee	24/10/2017
Governance Committee Chair	01/12/2016
Nominating Committee Chair	01/12/2016
Audit Committee
Finance Committee

Amy Miles

59 ans

Governance Committee	15/01/2025
Audit Committee Chair
Finance Committee Chair	01/04/2020
Audit Committee	15/01/2025
Nominating Committee	23/07/2020

Ellen Kullman

70 ans

Governance Committee Chair	08/05/2023
Nominating Committee Chair	08/05/2023
Governance Committee	21/12/2016
Nominating Committee	21/12/2016
Compensation Committee	21/12/2016

Omar Ishrak

71 ans

Audit Committee	01/08/2023
Compensation Committee	30/07/2021
Governance Committee	01/08/2023
Nominating Committee	01/08/2023

Mary Klotman

72 ans

Governance Committee	31/05/2024
Nominating Committee	11/11/2022
Compensation Committee	11/11/2022

Tyler Jacks

65 ans

Finance Committee	24/02/2015
Compensation Committee

Michael Drake

75 ans

Governance Committee	03/08/2022
Nominating Committee	03/08/2022

Brian Druker

70 ans

Compensation Committee

23/05/2018

Dernières Nominations: Amgen Inc.

19/05	Amgen Inc. annonce des changements au sein de sa direction exécutive	CI
04/05	Pasithea Therapeutics Corp. nomme Kartik Krishnan au poste de Chief Medical Officer, à compter du 1er mai 2026	CI
23/04	Santhera Pharmaceuticals Holding AG annonce un changement de Direction Générale	CI
22/04	Amgen annonce des remaniements au sein de sa direction, effectifs au 1er juin 2026	CI
22/04	BridgeBio Oncology Therapeutics, Inc. annonce un changement de direction générale	CI
22/04	PMV Pharmaceuticals, Inc. annonce des changements au sein de son conseil d'administration, effectifs au 4 juin 2026	CI
20/04	Sagimet Biosciences Inc annonce des changements au sein de sa direction, effectifs au 20 avril 2026	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Amgen Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Frank Herringer

Director/Board Member	01/05/2004	22/05/2019
Independent Dir/Board Member	22/04/2011	22/05/2019

David Baltimore

Director/Board Member	01/01/1997	22/05/2018
Independent Dir/Board Member	22/04/2011	22/05/2018

Frank J. Biondi

Director/Board Member	01/01/2002	19/05/2017
Independent Dir/Board Member	22/04/2011	19/05/2017

Judith C. Pelham

Director/Board Member	01/05/1995	19/05/2017
Independent Dir/Board Member	22/04/2011	19/05/2017

Rolf K. Hoffmann

Corporate Officer/Principal

01/11/2004

01/07/2016

Vance D. Coffman

Director/Board Member	02/10/2007	01/01/2016
Independent Dir/Board Member	22/04/2011	01/01/2016

Willard Dere

Chief Tech/Sci/R&D Officer	01/06/2007	01/10/2014
Corporate Officer/Principal	01/06/2007	01/06/2007

Joseph P. Miletich

Chief Tech/Sci/R&D Officer

01/04/2002

01/07/2014

Gilbert Omenn

Director/Board Member	01/01/1987	15/05/2014
Independent Dir/Board Member	22/04/2011	15/05/2014

Leonard Schaeffer

Director/Board Member	01/03/2004	08/07/2013
Independent Dir/Board Member	22/04/2011	08/07/2013

J. Reason

Director/Board Member	01/01/2001	22/05/2013
Independent Dir/Board Member	22/04/2011	22/05/2013

Fabrizio Bonanni

Chief Operating Officer

01/04/1999

01/01/2013

David Beier

Public Communications Contact	19/04/2011	08/10/2012
General Counsel	01/12/2003	08/10/2012
Corporate Officer/Principal	08/10/2012	01/01/2013

Kevin Sharer

Chief Executive Officer	01/01/2000	01/05/2012
Chairman	01/10/1992	31/12/2012
President	01/10/1992	01/01/2000

Roger Perlmutter

Chief Tech/Sci/R&D Officer

01/01/2001

12/02/2012

Roy Baynes

Corporate Officer/Principal

01/08/2002

01/01/2012

Frederick Gluck

Director/Board Member	01/02/1998	01/10/2011
Independent Dir/Board Member	22/04/2011	01/10/2011

Lisa Guttman

Corporate Officer/Principal

01/01/2000

01/10/2007

Richard Nanula

Director of Finance/CFO

01/08/2001

10/04/2007

Donald B. Rice

Director/Board Member

01/10/2000

17/01/2007

Lisa A. Evrén

Treasurer

01/01/2002

01/01/2007

Hassan A. Dayem

Chief Tech/Sci/R&D Officer

01/05/2002

20/09/2006

Timothy Martin

Comptroller/Controller/Auditor	01/08/2003	01/05/2006
Director of Finance/CFO	01/08/2003	01/05/2006

David Parkinson

Corporate Officer/Principal

01/05/2003

01/03/2006

Keith L. Klein

General Counsel

01/01/1991

01/01/2006

Edward V. Fritzky

Director/Board Member

01/07/2002

01/05/2005

Charles R. Bradley

Corporate Officer/Principal

01/01/2000

01/01/2005

Michael Narachi

Corporate Officer/Principal

01/07/1984

01/01/2003

Thomas James Flanagan

Chief Tech/Sci/R&D Officer

01/06/2004

Steve Lazarus

Director/Board Member

01/05/1987

13/05/2004

Patricia Cary Sueltz

Director/Board Member	08/01/2002	01/05/2004
Independent Dir/Board Member	08/01/2002	01/05/2004

David J. Scott

General Counsel	01/03/2004	-
Corporate Secretary	01/03/2004	-

Joseph J. Tsiakals

Corporate Officer/Principal

01/01/2000

01/01/2004

Bradley J. Maroni

Corporate Officer/Principal

01/01/1998

01/01/2004

Martha E. Vincent

Chief Tech/Sci/R&D Officer

01/01/1995

01/01/2004

Kevin Young

Corporate Officer/Principal

01/01/2001

01/01/2004

Wen-Tse Tseng

Corporate Officer/Principal

10/09/1998

10/09/2003

Diane M. Palumbo

Human Resources Officer

01/06/1991

01/07/2003

Carl LeBel

Corporate Officer/Principal

01/01/1993

David Hallal

Sales & Marketing

01/01/1992

01/08/2002

Nicholas Lydon

Corporate Officer/Principal

01/12/2000

02/01/2002

Robin D. Campbell

Corporate Officer/Principal

01/01/1989

01/01/2002

Brian M. McNamee

Human Resources Officer	01/06/2001	07/11/2013
Corporate Officer/Principal	07/11/2013	-

Matthew Moyle

Corporate Officer/Principal

01/01/1995

01/01/2001

Gordon Binder

Chief Executive Officer

01/01/1982

01/01/2000

Henry Wu

Corporate Officer/Principal

01/01/1999

Gisela Schwab

Chief Tech/Sci/R&D Officer

01/01/1992

Denny Lanfear

Corporate Officer/Principal

01/01/1986

01/01/1999

Jerry D. Choate

Director/Board Member	01/08/1998	-
Independent Dir/Board Member	22/04/2011	-

Julia Eastland

Comptroller/Controller/Auditor

01/03/1996

01/04/1998

Danute M. Bankaitis-Davis

Chief Tech/Sci/R&D Officer

01/01/1992

01/01/1998

Rosemary Mazanet

Chief Tech/Sci/R&D Officer

01/01/1993

01/01/1998

Kathleen M. Wiltsey

Sales & Marketing

01/01/1984

01/01/1998

Margaret E. Valeur-Jensen

Corporate Officer/Principal

01/01/1991

01/01/1998

Gregory Stea

Sales & Marketing

01/05/1988

01/01/1997

Peter García

Corporate Officer/Principal

01/01/1990

Richard Yeh

Corporate Officer/Principal

01/10/1995

Mark Moon

Corporate Officer/Principal

01/01/1989

02/01/1995

Lowell Sears

Director of Finance/CFO

01/01/1986

01/01/1994

Alan B. Forsythe

Corporate Officer/Principal

01/01/1991

G. Kirk Raab

Director/Board Member

01/01/1981

01/01/1985

Bertrand C. Liang

Corporate Officer/Principal

Joshua Disbrow

Corporate Officer/Principal

Alexander Lopez

Corporate Officer/Principal

Elaine Richardson

Corporate Officer/Principal

Howard J. Lewin

Corporate Officer/Principal

Edward H. Shin

Corporate Officer/Principal

David Polk

Public Communications Contact

Alec Green

Corporate Officer/Principal

Jeffrey D. Webster

Corporate Officer/Principal

M. Patricia Beckmann

Corporate Officer/Principal

Nancy Stuart

Corporate Officer/Principal

Ralph Niven

Corporate Officer/Principal

Kathleen Stafford

Treasurer

Steve Bandler

Corporate Officer/Principal

Sanjay Kanungo

Corporate Officer/Principal

Steven R. Wiley

Corporate Officer/Principal

James H. Chamberlain

Corporate Officer/Principal

John Shutter

Public Communications Contact

Luc Marengère

Corporate Officer/Principal

Ernest Allen

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	31
Femme	8

Dont comité exécutif

Homme	17
Femme	1

Dont Administrateurs

Homme	10
Femme	2

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Oui

Conforme à la finance Islamique

Non

Amgen Inc. figure parmi les 1ers groupes mondiaux de biotechnologie. Le CA par source de revenus se répartit comme suit : - ventes de médicaments (95,6%) : médicaments destinés au traitement des cancers, des troubles métaboliques, des maladies osseuses, des insuffisances rénales, de l'hémophilie, etc. ; - autres (4,4%) : notamment royalties. 71,9% du CA est réalisé aux Etats-Unis.

Employés

31 500

Secteur

Produits pharmaceutiques

Plus d'informations sur la société